Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083605

Options or other derivatives

  • Chief Operating Officer acquired 19,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jacobson Mark L. Chief Operating Officer 2026-02-26 Grant or award · Restricted Stock Units +19,663 19,663 D
Loading xslF345X05/ownership.xml…